Pfizer Reports Q1 2026 Earnings with Revenue and EPS Growth
Pfizer (PFE) reported Q1 2026 earnings with total revenue of $14.5 billion, a 2% operational increase, and adjusted diluted EPS of $0.75, exceeding internal expectations. The company also noted non-COVID revenue growth of approximately 7% and a 22% increase in revenue from launch and acquired products.
Tickers: $PFE
Topics: Acquisitions Dividend Earnings EPS Financial Performance Operating Margin Revenue